- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01971229
Gastric Emptying and Insulin Response to Test Drink
August 15, 2018 updated by: Franco Carli
Assessment of Insulin Response Following Ingestion of a Carbohydrate/Whey Protein Drink. A Cross-over Randomized Double Blind Study.
Surgery is a stress on the body and recovering well after surgery is very important to patients and their doctors.
It is therefore important to prepare patient's bodies for the stress of surgery, and one way to do this is to provide proper nutrition.
In the past, patients were asked to prepare for surgery by fasting from midnight before surgery.
Today, it is known that this practice is not beneficial to patient's recovery.
In fact, it has been recognized that drinking a sugary beverage (e.g., juice) before surgery stimulates the production of insulin, which is a hormone that helps make the proteins needed for wound healing after surgery.
This is currently practiced at the MUHC.
It might also be beneficial, however, to drink a beverage that contains sugar and whey proteins (a protein isolated from milk) before surgery.
In fact, whey proteins stimulate insulin and may also have the added benefit of improving muscular strength.
In this study, investigators will measure the level of insulin produced after drinking a carbohydrate (i.e., sugar)-whey protein beverage to determine how it compares to the level of insulin produced after drinking the sugary beverage used at the MUHC.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
It is hypothesized that the increase in plasma insulin following a mixed carbohydrate whey protein drink is significantly greater than that elicited by a carbohydrate drink.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3G 1A4
- Montreal General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteer
Exclusion Criteria:
- diabetes,
- neurological disorders
- chronic kidney failure
- chronic liver disease
- disorders of gastric motility
- gastro-esophageal reflux
- achalasia
- gastroparesis
- intestinal obstruction
- previous abdominal surgery
- lactose intolerance
- body mass index below 17 or above 29
- allergy to acetaminophen.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Carbohydrate
Patients in this arm will drink a 425 mL 100% clear apple juice (carbohydrate 50 g, 700 mOsmol).
1.5 g of acetaminophen will be dissolved in the beverage for determination of gastric emptying.
|
After consumption of the test drink to record the insulin response and gastric emptying.
After consumption of the test drink to record the insulin response and gastric emptying.
|
Active Comparator: Whey Protein
Patients in this arm will drink a 330 mL Boost fruit flavoured clear beverage (whey protein 12.2 g, carbohydrate 50 g, 700 mOsmol).1.5
g of acetaminophen will be dissolved in the beverage for determination of gastric emptying.
|
After consumption of the test drink to record the insulin response and gastric emptying.
After consumption of the test drink to record the insulin response and gastric emptying.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insulin response to a test meal
Time Frame: Change over 3 hours
|
Patients will consume a carbohydrate or a whey protein based drink and their insulin response will be monitored every 30 minutes for 3 hours.
|
Change over 3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastric emptying
Time Frame: Change over 3 hours
|
The acetaminophen absorption test, as an indirect assessment of gastric emptying.Since gastric emptying is the rate-limiting step in delivering the drug to its absorption site, it is believed that the rate of appearance of acetaminophen in the blood reflects the rate of gastric emptying. Blood samples will be collected every 30 minutes for 3 hours. |
Change over 3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Franco Carli, MD, Montreal General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
October 23, 2013
First Submitted That Met QC Criteria
October 28, 2013
First Posted (Estimate)
October 29, 2013
Study Record Updates
Last Update Posted (Actual)
August 17, 2018
Last Update Submitted That Met QC Criteria
August 15, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-168-BMA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Assiut UniversityCompleted
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
-
The University of Texas Medical Branch, GalvestonCompletedInsulin Resistance, DiabetesUnited States
-
University Health Network, TorontoCompletedInsulin Resistance, DiabetesCanada
Clinical Trials on Carbohydrate based drink
-
Jessica GrayUnknownPostoperative Complications | Postoperative Pain | Sleep | Satisfaction | Postoperative NauseaCanada
-
Coombe Women and Infants University HospitalRecruitingFasting | Glucose, Low Blood | Cesarean Delivery Affecting FetusIreland
-
University of ArizonaNova BiomedicalRecruitingCesarean Section | Enhanced Recovery After SurgeryUnited States
-
University of Western Ontario, CanadaUnknown
-
Medical University of GdanskRecruitingBariatric Surgery | Carbohydrate LoadingPoland
-
King's College LondonCompletedGlucose Metabolism Disorders | Appetitive BehaviorUnited Kingdom
-
University of OxfordUnknown
-
Hospital for Special Surgery, New YorkRecruitingLength of Stay | Same-day DischargeUnited States
-
University of OuluSeinajoki Central HospitalCompleted
-
McGill University Health Centre/Research Institute...Mitacs; Medtronic - MITGCompletedLaparoscopic Abdominal SurgeryCanada